Weekly Rundown: Tenaya Therapeutics' gene therapy for heart condition placed on hold ​​​​​Greater focus on non-animal testing methods in the UK, a new CRISPR treatment to lower cholesterol, and positive results for a BTK inhibitor in MS led the news this week.

https://www.drugdiscoverynews.com/weekly-rundown-tenaya-therapeutics-gene-therapy-for-heart-condition-placed-on-hold-16803?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-_WCH-xCZSlIiyzlp-6psIbY4_cll2elwOPtgNbMT6NcCKqxquA5HxfIXfWpd-6FPjRqUdJHwVy2kGCQpQnKe1Uu7W4_w&_hsmi=389952924&utm_content=389952924&utm_source=hs_email